Blood transfusion: The silent epidemic

Annals of Thoracic Surgery

Volumn 72, Issue 5, 2001, Pages

  Spiess, Bruce D ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; CONFERENCE PAPER; EVIDENCE BASED MEDICINE; HEPATITIS VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; VIRUS TRANSMISSION;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; HUMANS; IMMUNOCOMPROMISED HOST; RISK FACTORS;

EID: 0035163408     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03259-3     Document Type: Conference Paper

References (43)

1. Transfusion-transmitted hepatitis A, B and D
2. Transfusion-associated viral hepatitis
3. Jaundice occurring one to four months after transfusion of blood or plasma: Report of seven cases
4. Transfusion-associated hepatitis B past and present
5. Risk of post-transfusion hepatitis in the United States: A prospective cooperative study
6. Hepatitis C: Miles to go before we sleep
7. Non A-non-B hepatitis. I. Recognition, epidemiology, and clinical features
8. Controversies in transfusion medicine: Is autologous blood transfusion worth the cost?
9. Controversies in transfusion medicine: Is autologous blood transfusion worth the cost?
10. Autologous blood donation - Can we bank on it?
11. Protection against viral hepatitis. Recommendations of the Immunization Practice Advisory Committee (ACIP)
12. Indirect tests for transfusion-transmitted diseases
13. Hepatitis C, and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population
14. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma
15. Transfusion medicine. Blood transfusion
16. Prevelance of a newly described human cricovirus, TTV, in United States donors
17. Transfusion medicine and spongiform encephalopathy
18. The case against universal leukodepletion
19. Detection of circulating donor white blood cells in patients receiving multiple transfusions
20. Mononuclear cell microchimerism and the immunomodulatory effect of transfusion
21. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. II Activation of T cells, macrophages, and cell mediated lympholysis
22. Immunological abnormalities in haemophiliacs
23. Transfusion induced immunomodulation and its clinical consequences
24. The role of cytokines in blood transfusion reactions
25. Evaluation of pooled platelet concentrates using prestorage versus post storage WBC reduction: Impact of filtration timing
26. The role of red cell antigens, histocompatibility antigens and blood transfusions on renal allograft surbvival
27. The role of HLA matching and blood transfusions in the cyclosporin era
28. Perioperative blood transfusion and colorectal cancer recurrence: A qualitative statistical overview and meta-analysis
29. Blood transfusions and prognosis in colorectal cancer
30. Blood transfusions modulated tumor recurrence - A randomized study of autologous verusus homologous blood transfusion in colorectal cancer
31. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair
32. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusion
33. Association of transfusion with post-operative bacterial infection
34. Blood transfusion and infection after colorectal surgery
35. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery; effect of the length of storage of transfused red cells
36. RBC transfusion and postoperative length of stay in the hospital or the intensive care unit among patients undergoing coronary artery bypass graft surgery: The effects of confounding factors
37. A multicenter randomized, controlled clinical trial of transfusion requirements in critical care
38. Adverse outcomes with transfusion in coronary artery bypass, results from the aprotinin database
39. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery
40. Influence of haemoglobin concentration after extracorporeal circulation on mortality and morbidity in patients undergoing cardiac surgery
41. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting
42. Hematocrit value on ICU entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting